Marinus Pharmaceuticals Statistics
Total Valuation
Markel Group has a market cap or net worth of MXN 464.09 billion. The enterprise value is 486.60 billion.
Market Cap | 464.09B |
Enterprise Value | 486.60B |
Important Dates
The last earnings date was Friday, August 1, 2025.
Earnings Date | Aug 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 12.68M |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.60% |
Shares Change (QoQ) | -0.83% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 12.37M |
Valuation Ratios
The trailing PE ratio is 11.44 and the forward PE ratio is 19.40.
PE Ratio | 11.44 |
Forward PE | 19.40 |
PS Ratio | 1.50 |
PB Ratio | 1.38 |
P/TBV Ratio | 1.91 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.65, with an EV/FCF ratio of 12.60.
EV / Earnings | 12.00 |
EV / Sales | 1.57 |
EV / EBITDA | 6.65 |
EV / EBIT | 7.69 |
EV / FCF | 12.60 |
Financial Position
The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.24.
Current Ratio | 2.60 |
Quick Ratio | 0.94 |
Debt / Equity | 0.24 |
Debt / EBITDA | 1.12 |
Debt / FCF | 2.13 |
Interest Coverage | 15.88 |
Financial Efficiency
Return on equity (ROE) is 13.50% and return on invested capital (ROIC) is 9.74%.
Return on Equity (ROE) | 13.50% |
Return on Assets (ROA) | 3.32% |
Return on Invested Capital (ROIC) | 9.74% |
Return on Capital Employed (ROCE) | 5.99% |
Revenue Per Employee | 14.10M |
Profits Per Employee | 1.84M |
Employee Count | 22,000 |
Asset Turnover | 0.26 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Markel Group has paid 11.98 billion in taxes.
Income Tax | 11.98B |
Effective Tax Rate | 21.53% |
Stock Price Statistics
The stock price has increased by +31.49% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +31.49% |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 71.40 |
Average Volume (20 Days) | 214 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.96 |
Income Statement
In the last 12 months, Markel Group had revenue of MXN 310.30 billion and earned 40.56 billion in profits. Earnings per share was 3,150.30.
Revenue | 310.30B |
Gross Profit | 157.07B |
Operating Income | 63.30B |
Pretax Income | 55.63B |
Net Income | 40.56B |
EBITDA | 70.03B |
EBIT | 63.30B |
Earnings Per Share (EPS) | 3,150.30 |
Balance Sheet
The company has 105.88 billion in cash and 82.30 billion in debt, giving a net cash position of -12.15 billion.
Cash & Cash Equivalents | 105.88B |
Total Debt | 82.30B |
Net Cash | -12.15B |
Net Cash Per Share | n/a |
Equity (Book Value) | 336.96B |
Book Value Per Share | 25,808.81 |
Working Capital | 326.20B |
Cash Flow
In the last 12 months, operating cash flow was 42.72 billion and capital expenditures -4.10 billion, giving a free cash flow of 38.62 billion.
Operating Cash Flow | 42.72B |
Capital Expenditures | -4.10B |
Free Cash Flow | 38.62B |
FCF Per Share | n/a |
Margins
Gross margin is 50.62%, with operating and profit margins of 20.40% and 13.57%.
Gross Margin | 50.62% |
Operating Margin | 20.40% |
Pretax Margin | 17.93% |
Profit Margin | 13.57% |
EBITDA Margin | 22.57% |
EBIT Margin | 20.40% |
FCF Margin | 12.45% |
Dividends & Yields
Markel Group does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 1.61% |
Buyback Yield | 2.60% |
Shareholder Yield | n/a |
Earnings Yield | 8.74% |
FCF Yield | 8.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 6 |